Phase 1: Use of a potent agonist and a potent antagonist to test the standardized protocol, Env. Health Persp., 114:1265-1269.
Phase 1: Use of a potent agonist and a potent antagonist to test the standardized protocol. Env. Health Persp. 114:1265-1269.